Discover how new research is transforming 5-FU cancer treatment through pharmacokinetic reevaluation, improving safety and efficacy.
Explore the revolution in hemorheologic agents - from designer antibodies to pharmacokinetically-optimized dosing regimens that are transforming bleeding disorder treatments.
Exploring coDbait's pharmacokinetics and toxicity profile in preclinical studies with rats and monkeys, and its potential to revolutionize cancer therapy.